U.S. market Closed. Opens in 16 hours 49 minutes

BMRN | BioMarin Pharmaceutical Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for BMRN we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is passable.

Valuation (38%)

Company Industry
P/E Ratio (TTM) 62.90 -15.40
PEG Ratio (TTM) 6.73 -1.28
P/S Ratio (TTM) 6.24 47.91
P/B Ratio (TTM) 3.05 21.47
P/FCF Ratio (TTM) 75.95 5.35
Price to 5YR AVG Earnings Ratio 71.99 -0.30
Price to 5YR AVG FCF Ratio 708.78 -7.28

Profitability (25%)

Company Industry
ROA (TTM) 3.63% -2.96%
ROE (TTM) 5.08% 23.42%
Net Profit Margin (TTM) 9.91% -894.56%
ROIC 5YR AVG -0.27% 16.62%

Growth (90%)

4QTR AVG 3YR AVG 5YR AVG
EPS 67.20% 1,238.98% 810.24%
Revenue 4.61% 7.56% 10.33%
Net Income 69.64% 1,214.25% 796.42%
Cash Flow 59.41% 157.48% 84.15%

Health (54%)

Company Industry
Current Ratio (TTM) 3.05 5.73
Quick Ratio (TTM) 1.95 5.45
D/E Ratio (TTM) 0.21 -14.53
Interest Coverage (TTM) 13.08 3.88
Piotroski F-Score 5 5
Altman Z-Score 6.25 13.58
LTL to 5YR AVG FCF 26.01 0.21
Shares Outstanding Growth 5YR AVG 1.19% 117.96%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙